How to use RWD for provider engagement: 3 pharma best practices
During a recent panel discussion at Reuters Events Pharma Marketing USA, leading pharma executives...
3 reasons it’s time to shift the paradigm for real world data in pharma
Patient-level, real-world data (RWD) in pharma has been used for years to inform drug development...
AI-driven risk prediction: A powerful underwriting tool in an era of high inflation
Anyone who has purchased groceries or filled up at a gas station recently has felt the pinch of...
Prevent drug launch failure with an end-to-end RWD solution
Wall Street expectations and enthusiasm have been high surrounding the biotechnology and...
3 Steps to Faster Patient Journey Mapping for Pharma Brand Success
Understanding the longitudinal patient journey — from symptoms to testing, to diagnosis and...
Highlights from The Data Ecosystem in 2025
Datavant, the leader in helping healthcare organizations securely connect their data and a Prognos...
Patient-centric vs. source-centric RWD curation: Which is better?
As a life science organization, you have several options when it comes to securing patient level...
The Prognos/BHI partnership: 5 reasons their joint medical underwriting risk predictor is a straighter path to underwriting accuracy
The Prognos/BHI partnership: 5 reasons their joint medical underwriting risk predictor is a...
Your 5-Point Checklist for Fueling Pharma Omnichannel Marketing With RWD
Life science organizations have moved away from traditional marketing models in favor of an...
Get a risk prediction edge with lab data: Two characteristics vital to health underwriting accuracy
Predicting risk in health insurance underwriting requires an accurate snapshot of a prospective...